Over the last five years Pfizer (NYSE:PFE) has delivered 67% price appreciation plus healthy dividends, compared with a 49% gain for the S&P 500 Index. Will the next five years be as good? Here are five reasons they could be even better.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,